Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study.
about
Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysisA pro-atherogenic HDL profile in coronary heart disease patients: an iTRAQ labelling-based proteomic approachSpeciated human high-density lipoprotein protein proximity profilesIdentification of proteomic biomarkers in maternal plasma in the early second trimester that predict the subsequent development of gestational diabetes.The Association between Apolipoprotein A-II and Metabolic Syndrome in Korean Adults: A Comparison Study of Apolipoprotein A-I and Apolipoprotein BApolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.APO A2 -265T/C Polymorphism Is Associated with Increased Inflammatory Responses in Patients with Type 2 Diabetes Mellitus.The fallacies of the lipid hypothesis.Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis.The interaction between ApoA2 -265T>C polymorphism and dietary fatty acids intake on oxidative stress in patients with type 2 diabetes mellitus.Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.
P2860
Q26860467-8D3D9304-C464-4EF9-B46E-2C0F78A00412Q33655192-2AF2F715-021F-4634-92C9-E89BD01F3DE1Q33745525-D972A3A1-9805-4255-B059-D30E7A320BD6Q34078908-57F9C507-D050-411A-BF3E-4EAEBC1399BBQ35770053-30E8430D-3798-42D9-9A51-ABF83A34746AQ35802050-7B3ECF4F-9ECB-4EFB-9B52-7840B1919057Q37056843-938F21A6-C17D-40A1-98B5-77318314AD33Q37211905-91A322C6-7FFF-4EDD-9750-0BED451649C8Q37434362-F42013AE-F9D9-457D-A135-55A7D2D51D36Q37866321-8381F3FF-ED07-441D-9353-D80A5C0F4518Q40714647-442E52FB-FAAD-493B-A123-16208B6D7AA3Q41293822-59239A6F-2577-4C22-9026-4D1E9343F88E
P2860
Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Plasma lipoproteins, apoprotei ...... . A nine-year follow-up study.
@en
Plasma lipoproteins, apoprotei ...... . A nine-year follow-up study.
@nl
type
label
Plasma lipoproteins, apoprotei ...... . A nine-year follow-up study.
@en
Plasma lipoproteins, apoprotei ...... . A nine-year follow-up study.
@nl
prefLabel
Plasma lipoproteins, apoprotei ...... . A nine-year follow-up study.
@en
Plasma lipoproteins, apoprotei ...... . A nine-year follow-up study.
@nl
P2093
P1476
Plasma lipoproteins, apoprotei ...... . A nine-year follow-up study.
@en
P2093
Crepaldi G
Minicuci N
Roselli della Rovere G
Rossetti C
P356
10.1016/S0939-4753(03)80167-9
P577
2003-02-01T00:00:00Z